J&J Starts SKYWARD Study of Carotid IVL System

J&J starts SKYWARD study of carotid IVL system

J&J has begun enrolment in its SKYWARD IDE clinical programme to evaluate the Shockwave SkyRunner Carotid IVL system.The post J&J starts SKYWARD study of carotid IVL system appeared first on Hospital Management.

Shockwave Medical announces new studies evaluating carotid IVL platform

Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.

J&J begins enrolment in pivotal studies evaluating first-of-its-kind carotid IVL platform

Nicolas Mouawad Johnson & Johnson (J&J) announced today the initiation of its SKYWARD investigational device exemption (IDE) clinical programme evaluating the novel Shockwave SkyRunner carotid intravascular lithotripsy (IVL) system for the treatment of calcified carotid arteries prior to stenting. The first patient was treated by Nicolas Mouawad (McLaren Bay Region Hospital, Bay City, USA). “Calcium in the carotid artery is a major clinical chal…